D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 41 Citations 6,782 107 World Ranking 3552 National Ranking 2

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Cancer
  • Internal medicine

Radek Spisek spends much of his time researching Immunology, Immune system, Immunogenic cell death, Cancer cell and Immunotherapy. His research integrates issues of Cytotoxic T cell and CD40 in his study of Immunology. The concepts of his Immune system study are interwoven with issues in Monoclonal antibody, Cytokine, Antigen and Cell biology.

His Immunogenic cell death research is multidisciplinary, incorporating perspectives in Calreticulin, Mitoxantrone and Doxorubicin. His work deals with themes such as Acquired immune system and Translational medicine, which intersect with Cancer cell. As part of one scientific family, Radek Spisek deals mainly with the area of Cancer immunotherapy, narrowing it down to issues related to the Cancer research, and often T lymphocyte.

His most cited work include:

  • Consensus guidelines for the detection of immunogenic cell death (449 citations)
  • Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. (289 citations)
  • Classification of current anticancer immunotherapies (249 citations)

What are the main themes of his work throughout his whole career to date?

Radek Spisek mainly focuses on Immune system, Immunology, Cancer research, Immunotherapy and Cancer. His research in Immune system intersects with topics in Cancer cell and Antigen. As a part of the same scientific study, he usually deals with the Cancer cell, concentrating on Calreticulin and frequently concerns with CD86 and Interferon.

His research brings together the fields of CD40 and Immunology. His Cancer research research includes elements of Cytotoxic T cell, Receptor, CD8 and Cancer immunotherapy. His Immunotherapy research incorporates elements of Clinical trial, Lung cancer, Oncology, Urology and Interleukin 12.

He most often published in these fields:

  • Immune system (48.48%)
  • Immunology (45.45%)
  • Cancer research (33.33%)

What were the highlights of his more recent work (between 2018-2021)?

  • Immune system (48.48%)
  • Cancer research (33.33%)
  • Cancer cell (18.18%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Immune system, Cancer research, Cancer cell, Tumor microenvironment and CD8. His Immune system research is multidisciplinary, incorporating elements of Oncology, Cytokine and Antigen. His Cancer research study combines topics in areas such as Cytotoxic T cell, Receptor and Cytokine milieu.

Radek Spisek studies Cancer cell, focusing on Immunogenic cell death in particular. His Central tolerance study is concerned with the field of Immunology as a whole. His biological study deals with issues like Mesenchymal stem cell, which deal with fields such as Diabetes mellitus.

Between 2018 and 2021, his most popular works were:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (106 citations)
  • Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. (36 citations)
  • TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer (30 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Cancer
  • Internal medicine

Radek Spisek focuses on Immune system, Cancer research, Immunogenic cell death, Acquired immune system and Immunotherapy. His Immune system research is within the category of Immunology. His Immunology study incorporates themes from Diabetes mellitus, Glycation, Insulin and Pancreas.

He has researched Cancer research in several fields, including Immune checkpoint, Cytotoxic T cell, Calreticulin and CD20. His studies deal with areas such as Adjuvanticity, Neuroscience and Antigen presentation as well as Acquired immune system. His work carried out in the field of Immunotherapy brings together such families of science as Cytokine, Clinical trial and Oncology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Consensus guidelines for the detection of immunogenic cell death

Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli.
OncoImmunology (2014)

545 Citations

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

Radek Spisek;Anna Charalambous;Amitabha Mazumder;David H. Vesole.
Blood (2007)

441 Citations

Classification of current anticancer immunotherapies

Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué.
Oncotarget (2014)

340 Citations

Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response

Jitka Fucikova;Petra Kralikova;Anna Fialova;Tomas Brtnicky.
Cancer Research (2011)

281 Citations

Combinatorial Strategies for the Induction of Immunogenic Cell Death

Lucillia Bezu;Ligia C. Gomes-de-Silva;Heleen Dewitte;Karine Breckpot.
Frontiers in Immunology (2015)

271 Citations

Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3 + CD4 + regulatory T cells from peripheral Foxp3 − precursors

Sayuri Yamazaki;Anthony J. Bonito;Radek Spisek;Madhav Dhodapkar.
Blood (2007)

252 Citations

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert.
Frontiers in Immunology (2015)

238 Citations

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

Jonathan Pol;Erika Vacchelli;Fernando Aranda;Francesca Castoldi.
OncoImmunology (2015)

187 Citations

Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors

Daniela Rozkova;Rudolf Horvath;Jirina Bartunkova;Radek Spisek.
Clinical Immunology (2006)

184 Citations

Frequent and specific immunity to the embryonal stem cell–associated antigen SOX2 in patients with monoclonal gammopathy

Radek Spisek;Anjli Kukreja;Lin-Chi Chen;Phillip Matthews.
Journal of Experimental Medicine (2007)

184 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Radek Spisek

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 159

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 127

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 87

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 55

Patrizia Agostinis

Patrizia Agostinis

KU Leuven

Publications: 48

Madhav V. Dhodapkar

Madhav V. Dhodapkar

Emory University

Publications: 44

Erika Vacchelli

Erika Vacchelli

Institut Gustave Roussy

Publications: 28

Lionel Apetoh

Lionel Apetoh

Inserm : Institut national de la santé et de la recherche médicale

Publications: 28

Takahiro Yamazaki

Takahiro Yamazaki

Cornell University

Publications: 25

Dmitri V. Krysko

Dmitri V. Krysko

Ghent University

Publications: 21

François Ghiringhelli

François Ghiringhelli

Inserm : Institut national de la santé et de la recherche médicale

Publications: 20

Laura Senovilla

Laura Senovilla

Université Paris Cité

Publications: 20

Antoine Tesniere

Antoine Tesniere

Université Paris Cité

Publications: 18

Isabelle Martins

Isabelle Martins

Inserm : Institut national de la santé et de la recherche médicale

Publications: 18

Peter Vandenabeele

Peter Vandenabeele

Ghent University

Publications: 17

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 16

Trending Scientists

Ron Shamir

Ron Shamir

Tel Aviv University

Keshav Pingali

Keshav Pingali

The University of Texas at Austin

Brenton S. McLaury

Brenton S. McLaury

University of Tulsa

Yutai Katoh

Yutai Katoh

Oak Ridge National Laboratory

Gabriel P. Lopez

Gabriel P. Lopez

University of New Mexico

Basharat Ali

Basharat Ali

University of Agriculture Faisalabad

Grant Morahan

Grant Morahan

Harry Perkins Institute of Medical Research

Ruud B.M. Huirne

Ruud B.M. Huirne

Wageningen University & Research

Bernhard Kuster

Bernhard Kuster

Technical University of Munich

Francis T. Wu

Francis T. Wu

Binghamton University

Marek Zreda

Marek Zreda

University of Arizona

Ed Hawkins

Ed Hawkins

University of Reading

Johannes F. Scheid

Johannes F. Scheid

Harvard University

Marjorie L. McCullough

Marjorie L. McCullough

American Cancer Society

Jean-Paul Sculier

Jean-Paul Sculier

Université Libre de Bruxelles

Marius R. Busemeyer

Marius R. Busemeyer

University of Konstanz

Something went wrong. Please try again later.